Free Trial
Fall Lock-In Sale! MarketBeat All Access, $149 a Year for Life
Lock In $149
Claim MarketBeat All Access Sale Promotion
NYSE:ARDT

Ardent Health Q3 2026 Earnings Date & Estimates

Ardent Health logo
$12.18 -0.09 (-0.69%)
Closing price 03:59 PM Eastern
Extended Trading
$12.18 -0.01 (-0.04%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Ardent Health is estimated to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. The conference call is scheduled for November 5, 2026 at 10:00 AM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call Date
Conference Call
10:00 AM ET

What Analysts Expect from Ardent Health in Q3 2026

Ardent Health is expected to post earnings of $0.2354 per share on revenue of $1.60 billion. In the same quarter a year earlier Ardent Health reported $0.52 per share on revenue of $1.58 billion. Ardent Health last reported on August 4, 2026, posting $0.12 per share and missing the $0.1817 consensus estimate. Ardent Health has beaten the consensus EPS estimate in 5 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$0.2354
Expected Revenue
$1.60 billion
Prior-Year EPS
$0.52
Prior-Year Revenue
$1.58 billion
Expected EPS Growth
-54.7%
Expected Revenue Growth
+1.7%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.12 (Missed by -$0.0617)
Last Quarter Revenue
$1.62 billion
EPS Beat Rate
5 of last 8 quarters

Ardent Health Q3 2026 Earnings FAQ

Ardent Health (NYSE:ARDT) is estimated to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Ardent Health's Q3 2026 earnings conference call is scheduled for Thursday, November 5, 2026 at 10:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Ardent Health to post earnings of $0.2354 per share for Q3 2026.

The consensus revenue estimate for Ardent Health is $1.60 billion for Q3 2026.

Ardent Health Earnings Headlines

How New Digital Chief Will Impact Ardent Health (ARDT) Stock
Ardent Health (ARDT) Stock Looks Like A Bargain As It Gains 43% YTD
Nvidia's $550 Trillion Problem
Do not buy another AI stock until you've seen the arithmetic below. Nvidia is worth about $5.5 trillion. Alphabet about $4.1 trillion. Microsoft about $3.8 trillion. So what would it take to repeat Nvidia's run? A 100x gain from here puts Nvidia near $550 trillion. Nothing in history has ever been worth that. Big money in Nvidia has already been made. By the people who bought it years ago. But that does not mean the AI boom is finished. It means the opportunity has moved underneath it... to the layer every AI company has to pay to use.tc pixel
Ardent Health, Inc. (ARDT)
See More Ardent Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Ardent Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ardent Health and other key companies, straight to your email.

About Ardent Health

Ardent Health (NYSE:ARDT) is a U.S. healthcare services company that operates hospitals, outpatient facilities and physician practices. Its services include emergency and acute care, surgery, cardiology, orthopedics, oncology, women’s health, behavioral health, rehabilitation, imaging and other specialty and primary care offerings.

The company serves patients through regional health networks and hospital campuses primarily in Texas, Oklahoma, New Mexico and other U.S. markets. In addition to hospital-based care, Ardent operates outpatient clinics, urgent care locations and other facilities designed to provide services across different stages of the patient-care process.

Ardent Health was founded in 2001 and became a publicly traded company on the New York Stock Exchange in 2024. Marty Bonick serves as the company’s president and chief executive officer. Ardent’s operations include partnerships and affiliations with academic and community healthcare organizations, supporting both clinical care and specialty services.

View Ardent Health Profile